Ohcanbohtosat - Tom Cantor

  • Čájehuvvo 1 - 6 / 6
Aiddostahte ozu
  1. 1
    Lack of Comparability of Intact Parathyroid Hormone Measurements among Commercial Assays for End-Stage Renal Disease Patients: Implication for Treatment Decisions

    Lack of Comparability of Intact Parathyroid Hormone Measurements among Commercial Assays for End-Stage Renal Disease Patients: Implication for Treatment Decisions Dahkki Tom Cantor, Zan Wei Yang, Nicolae S. Caraiani, Ekambaram Ilamathi

    Almmustuhtton 2006
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Bone Mineral Density and Serum Biochemical Predictors of Bone Loss in Patients with CKD on Dialysis

    Bone Mineral Density and Serum Biochemical Predictors of Bone Loss in Patients with CKD on Dialysis Dahkki Hartmut H. Malluche, Daniel L. Davenport, Tom Cantor, Marie‐Claude Monier‐Faugere

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    A Novel Immunoradiometric Assay Detects Full-Length Human PTH but not Amino-Terminally Truncated Fragments: Implications for PTH Measurements in Renal Failure

    A Novel Immunoradiometric Assay Detects Full-Length Human PTH but not Amino-Terminally Truncated Fragments: Implications for PTH Measurements in Renal Failure Dahkki Markus R. John, William G. Goodman, Ping Gao, Tom Cantor, Isidro B. Salusky, H. Jüppner

    Almmustuhtton 1999
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Clinical Utility of an Immunoradiometric Assay for Parathyroid Hormone (1–84) in Primary Hyperparathyroidism

    Clinical Utility of an Immunoradiometric Assay for Parathyroid Hormone (1–84) in Primary Hyperparathyroidism Dahkki Shonni J. Silverberg, Ping Gao, Ijeoma Brown, P LoGerfo, Tom Cantor, John P. Bilezikian

    Almmustuhtton 2003
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients

    Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients Dahkki Marie-Claude Monier-Faugere, Zhaopo Geng, Hanna Mawad, Robert M. Friedler, Ping Gao, Tom Cantor, Hartmut H. Malluche

    Almmustuhtton 2001
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    An N-Terminal Molecular Form of Parathyroid Hormone (PTH) Distinct from hPTH(1–84) Is Overproduced in Parathyroid Carcinoma

    An N-Terminal Molecular Form of Parathyroid Hormone (PTH) Distinct from hPTH(1–84) Is Overproduced in Parathyroid Carcinoma Dahkki Mishaela R. Rubin, Shonni J. Silverberg, P D'Amour, Jean‐Hugues Brossard, Louise Rousseau, James Sliney, Tom Cantor, John P. Bilezikian

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: